AlveoliX and twelve other Swiss startups have successfully passed the 2019 cutoff of the Eurostars program from the European Commission. Starting from March 2019, the project AIM4DOC, will support the company in developing an Advanced Inhalation Model for Drug Discovery on Chip.

Learn more